Loading... Please wait...

Conduit Pharmaceuticals Inc. (CDTTW) Stock Price, News & Analysis

Currency in USD Disclaimer
$0.04 $0.01 (20.5%)
$0.04
$0.04
$0.04
$0.04

Company brief: Conduit Pharmaceuticals Inc. (CDTTW)


Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.

Price Target and Rating


  • $0.00
  • $0.00
  • $0.00
  • N/A
  • N/A
  • N/A
  • N/A

Profitability


  • $0.00
  • N/A
  • N/A
  • N/A
  • $-535,000

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.


×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.